Also the fact that there is no
vaccine against hcv was, may be, one of the reasons that led the
companies to focus on a curative treatment. Anyway, it is very promising now that the companies have shifted their focus towards hbv; so let's hope in the near future we would have a drug that could dislodge the cccDNA.
Let's also hope that any drugs that could be produced would be affordable to the general public, because the new hcv drugs are prohibitively expensive.